Effect of fluvastatin and fenofibrate on reactive oxygen species generation and lipid peroxidation in patients with dyslipidaemia;Wpływ fluwastatyny i fenofibratu na wytwarzanie reaktywnych form tlenu i peroksydacjȩ lipidów u chorych z dyslipidemia̧

Polski Merkuriusz Lekarski

Volumn 14, Issue 82, 2003, Pages 279-284

  Kowalski, Jan ^a   Błaszczyk, Jan ^a   Olejniczak, Jarosław ^a,b   Kowalski, Marcin ^a   Błaszczyk Suszyńska, Joanna ^a   Petecka, Edyta ^a   Kȩdziora, Józef ^a   Gburek, Jolanta ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Oddzial Kardiologiczny Szpital   (Poland)

Author keywords

Dyslipidemia; Malonyl dialdehyde; Reactive oxygen species; Stable angina pectoris

Indexed keywords

FENOFIBRATE; FLUINDOSTATIN; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; DYSLIPIDEMIA; ERYTHROCYTE; FEMALE; HUMAN; HYPERLIPIDEMIA; LIPID PEROXIDATION; MALE; NEUTROPHIL; STABLE ANGINA PECTORIS; TREATMENT PLANNING;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; ANTILIPEMIC AGENTS; FATTY ACIDS, MONOUNSATURATED; FEMALE; HUMANS; HYPERLIPIDEMIAS; INDOLES; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; PROCETOFEN; REACTIVE OXYGEN SPECIES;

EID: 0038374775     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Aviram M. i wsp.: Lovastatin inhibits low-density lipoprotein oxidation and altered its fluidity and uptake by macrophage: in vitro and vivo studies. Metabolism, 1992, 41. 229-235.
2. Aviram M. i wsp.: Atrovastatin and gemfibrozil metabolites, but not the parent drugs are potent antioxidants against lipoprotein oxidation. Atherosclerosis, 1998. 138, 271-280.
3. Bellavite P. i wsp.: The measurement of superoxide anion production by granulocytes in whole blood. A clinical test for the evaluation of fagocyte function and serum opsonic capacity. Eur. J. Clin. Invest., 1983, 13, 363-368.
4. Bertrand Y.: Oxygen-free radicals and lipid peroxidation in ARDS adult respiratory distress syndrome. Intern. Care Med., 1985, 11, 56-60.
5. Broncel M.: Skuteczność terapii statynami u pacjentów z dysplidemia̧ typu II- wpływ na lipidogram osocza, wybrane czynniki hemostazy i strukturȩ blony ertytrocytarnej. Rozprawa doktorska, WAM. Łódź. 2001.
6. Cristal R.G., Raven J.B.: The Lungs. Press, New York. 1991.
7. Dȩbczyński W. i wsp.: Badanie aktywności ludzkich granulocytów obojȩtnochłonnych w hiperlipidemi. Pol Tyg. Lek., 1996, 51, 19, 269-271.
8. Ferrari R. i wsp.: Oxygen free radicals and myocardial damage - protective role of thiol-containing agents. Am. J. Med, 1991, 91, 95-105.
9. Goldhaber J.I., Weiss J.N.: Oxygen free radicals and cardiac reperfusion abnormalities. Hypertension, 1992, 20, 118-127.
10. Hara A. i wsp.: Lidocaine attenuates both mechanical and metabolic changes induced by hydrogen peroxide in the rat heart. Am J Physiol., 1993. 265. H 1478-H 1485.
11. Hawley H.P., Gordon G.B.: The effects of long chain free fatty acids on human neutrophil function and structure Lab. Invest., 1976, 34, 216-223.
12. Hussein O. i wsp.: Reduced susceptibility of LDL to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL. Atherosclerosis. 1997. 128, 11-18.
13. Jayakumari N., i wsp.: Antioxidant status in relation to free radical production during stable and unstable anginal syndromes. Atherosclerosis, 1992, 94, 183-190.
14. Kowalski J.: Ocena stanu czynnościowego neutrofilów w niedokrwiennoreperfuzyjnym uszkodzeniu miȩśnia sercowego. Rozprawa habilitacyjna, WAM. Łódź. 1995.
15. Kowalski J., i wsp.: Przezskórna angioplastyka tȩtnicy wieńcowej (PTCA) zwiȩksza miejscowa̧ aktywacjȩ neutrofilów. Kardiol. Pol., 1995, 42, 205-210.
16. Laurindo F.R.M., i wsp.: Vascular free radical release - ex vivo and in vivo evidence for a flow-dependent endothelial mechanism. Circ. Res., 1994, 74, 700-709.
17. Mezes M.: Vitamine E content and lipid peroxidation of blood in some chronic inflammatory diseases. Acta Physiol. Hung., 1987, 69, 133-138.
18. O' Brien K., Chait A.: The biology of the artery wall in atherogenesis Lipid Disord., 1994, 78, 41-67.
19. Opperman P., Rosolski T.: Freie Radicale in ihre Bedeutung für die intensivtherapie. Anesthesiol. Reanimat., 1988, 13, 3-18.
20. Placer Z. i wsp.: Estimation of products of lipid peroxidation, malonyldialdehyde, in biochemical systems. Anal. Biochem., 1966, 16, 359-364.
21. Ranaut K. i wsp.: Effect of 7-oxo-PG12 on myocardial infarct size and role of oxygen radicals in its protective effects. Arch. Int. Pharmacodyn. Ther., 1993, 324, 75-86.
22. Repine J.E.: Oxidant antioxidant balance - some observations from studies of ischemia reperfusion in isolated perfused rat hearts. Am. J. Med., 1991, 91, 45-53.
23. Siminiak T., Ozawa T.: Neutrophil mediated myocardial injury. Int. J. Biochem., 1993, 25, 147-156.
24. Siminiak T i wsp.: Evidence for plasma-mediated neutrophil superoxide anion production during myocardial infarction. Cardiology, 1993, 82, 377-382.
25. Steinbrecher U.P., i wsp.: Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of density lipoprotein phospholipids. Proc. Natl Acad. Sci., 1984, 81, 3883-3887.
26. Tkaczewski W. i wsp.: Blood platelets aggregation, malonyl dialdehyde concentration and SOD-1 activity in patients with coronary heart disease after captopril administration. In: Current advances in ACE inhibition (ed. Mac Gregor G.A., Sever P.S.). London. 1989, 191-193.
27. Wysocki J.: Badania niektórych wskaźników immunologicznych i lipidowych w hiperlipidemiach pierwotnych. Rozprawa habilitacyjna. Katowice. 1990.
28. Wysocki H. i wsp.: Rola granulocytów obojȩtnochtonnych w procesach niedokrwiennych miȩśnia sercowego. Kardiol. Pol., 1989, 37, 35-40.